期刊文献+

甲状腺乳头状癌患者肿瘤组织和血清中miR-21的表达及其意义 被引量:2

The expression of miR-21 in carcinoma tissues and serum of patients with papillary thyroid carcinoma
原文传递
导出
摘要 目的检测miR-21在甲状腺乳头状癌(PTC)患者肿瘤组织和血清中的表达情况,探讨其临床意义。方法采用实时荧光定量聚合酶链反应(Real-time RT-PCR)检测46例PTC患者肿瘤组织和血清中miR-21表达情况,并与35例结节性甲状腺肿患者和18例正常人进行对比分析。结果 PTC患者肿瘤组织和血清miR-21表达相对水平为2.74±1.53和0.21±0.08,明显高于结节性甲状腺肿患者(0.92±0.81和0.08±0.05)和正常人(0.86±0.39和0.07±0.03)(P<0.05)。PTC患者肿瘤组织和血清中miR-21表达具有一致性。PTC患者肿瘤组织和血清中miR-21的表达与腺外侵润、远处转移、淋巴结转移和不同TNM分期有关(P<0.05)。结论 miR-21在PTC患者肿瘤组织和血清中的表达明显升高,且其表达水平与PTC临床病理特征相关,可能是新的PTC早期检测指标。临床上对于PTC肿瘤组织和血清中miR-21的检测可能用于PTC早期临床诊断。 Objective To investigates the expression of miR-21 in carcinoma tissues and serum of patients with papillary thyroid carcinoma( PTC) and its significance. Methods Reverse transcription polymerase chain reaction( RT-PCR) was used to detect the expression levels of miR-21 in carcinoma tissues and serum of 43 cases of 46 patients with PTC,and also compared with 35 cases of nodular goiter and 18 healthy people. The correlations of miR-21 expression to the clinicopathological features and prognosis were analyzed. Results The relative content of miR-21 in carcinoma tissues and serum of 46 patients with PTC was 2. 74±1. 53 and 0. 21 ±0. 08,and it was 0. 92 ±0. 81 and 0. 08 ±0. 05 in carcinoma tissues and serum of 35 patients with nodular,0.86±0. 39 and 0. 07±0. 03 in normal tissues and serum of 18 healthy people. The expression of miR-21 in carcinoma tissues was consistent with that in serum. The expression of miR-21 in carcinoma tissues and serum of patients with PTC was higher than that of patients with nodular goiter and healthy people( P〈0. 05). The expression level of miR-21 had a correlation with extraglandular invasion,distant metastasis,lymphatic metastasis and TNM classification( P〈0. 05). Conclusion The expression of miR-21 in carcinoma tissues and serum of patients with PTC was higher than that of patients with nodular goiter and healthy people,and the up-regulated expression of serum miR-21 is correlated with the clinicopathologic features of PTC,indicating that miR-21 could be used as a potential marker for early detection of PTC.
出处 《中国地方病防治》 2014年第5期371-373,共3页 Chinese Journal of Control of Endemic Diseases
关键词 甲状腺乳头状癌 MIR-21 组织 血清 Papillary thyroid carcinoma miR-21 Tissue Serum
  • 相关文献

参考文献3

二级参考文献34

  • 1刘东海,张乐鸣,张顺,毛联钢,冯伟云.乳腺癌患者c-erBb-2基因荧光定量PCR方法的研究[J].中国病理生理杂志,2006,22(2):380-383. 被引量:1
  • 2Ambros V.MicroRNA pathways in flies and worms:growth,death,fat,stress,and timing[J].Cell,2003,113(6):673-676.
  • 3Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer[J].Cancer Res,2005,65(16):7065-7070.
  • 4Chan JA,Krichevsky AM,Kosik KS.MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells[J].Cancer Res,2005,65(14):6029-6033.
  • 5Yanaihara N,Caplen N,Bowman E,et al.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J].Cancer Cell,2006,9(3):189-198.
  • 6Singletary SE,Allred C,Ashley P,et al.Staging system for breast cancer:revisions for the 6th edition of the AJCC Cancer Staging Manual[J].Surg Clin North Am,2003,83(4):803-819.
  • 7Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method[J].Methods,2001,25(4):402-408.
  • 8Gramantieri L,Ferracin M,Fornari F,et al.Cyclin G1 is a target of miR-122a,a microRNA frequently down-regulated in human hepatocellular carcinoma[J].Cancer Res,2007,67(13):6092-6099.
  • 9Rhodes A,Jasani B,Anderson E,et al.Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors:a comparative study involving results from laboratories in 21 countries[J].Am J Clin Pathol,2002,118(3):408-417.
  • 10Si ML,Zhu S,Wu H,et al.miR-21-mediated tumor growth[J].Oncogene,2007,26(19):2799-2803.

共引文献69

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部